Meredith Cummins

CEO Neuro Endocrine Cancer Australia (NECA); CNSA Co Vice President / Chair Finance & Risk Committee; CNSA Board – External Relations Director; CoNNMO Council Member; International Neuroendocrine Cancer Alliance (INCA) Board of Directors

Closing the NET on rare cancers thumbnail image

Health & Medicine

Closing the NET on rare cancers

Patients with neuroendocrine tumours (NETs) can access cutting-edge treatments and research technology thanks to a new partnership between doctors and scientists

Subscribe for your weekly email digest

By subscribing, you agree to our

Acknowledgement of country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities
Phone: 13 MELB (13 6352) | International: +61 3 9035 5511The University of Melbourne ABN: 84 002 705 224CRICOS Provider Code: 00116K (visa information)